InDex Pharmaceuticals Holding AB (publ) interim report January

/PRNewswire/ -- "We have now several clinics activated in the phase III study CONCLUDE and look forward to enrol the first patient in the near term", says...

Related Keywords

Sweden ,Hungary ,Canada ,Stockholm ,France ,Swedish ,Peter Zerhouni ,Erik Penser Bank ,Index Pharmaceuticals Holding ,Kindex Pharmaceuticals ,Company Certified Adviser ,Abuse Regulation ,Dex Pharmaceuticals ,Immunomodulatory Sequences ,Nasdaq First North Growth Market ,